Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02639559 · OUTCOME

Median Peripheral Blood CD34+ Cell Count (Arm 1 Donor Only)

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies · Source last updated 2023-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
CD34/microliters
Interval / dispersion
Full Range
Time frame
At 3-4 hours after BL-8040

Analysis population: Recipients are not evaluable for this outcome measure.

Groups in this outcome

Arm 1: Donors

-Donors will receive subcutaneous (SC) BL-8040 in the morning (Day 1) followed by leukapheresis approximately 180 minutes (up to 270 minutes) after the injection per institutional protocol. If the donor does not reach the collection goal for mobilization (≥ 5.0 x 10\^6 CD34+ cells/kg), a second leukapheresis will be performed on Day 2 (24 hours ± 2 hours from the BL-8040 injection) in an effort to reach a total of ≥ 5 x 10\^6 CD34+ cells/kg and at least ≥ 2 x 10\^6 CD34+ cells/kg from the combined collections.

Arm 2: Recipients

-All or part of the leukapheresis product will be infused into the recipient per institutional guidelines. The day of the infusion will be considered Day 0; if the infusion occurs over multiple days, the final day of infusion will be considered Day 0

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm 1: Donors25
Arm 2: Recipients0

Reported measurements

Source class 1
Values in CD34/microliters · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Arm 1: Donors15Not reported146Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        1
        upper Limit
        46
        value
        15
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    2. group Id
      OG001
      value
      0
    units
    Participants
dispersion Type
Full Range
groups
  1. description
    -Donors will receive subcutaneous (SC) BL-8040 in the morning (Day 1) followed by leukapheresis approximately 180 minutes (up to 270 minutes) after the injection per institutional protocol. If the donor does not reach the collection goal for mobilization (≥ 5.0 x 10\^6 CD34+ cells/kg), a second leukapheresis will be performed on Day 2 (24 hours ± 2 hours from the BL-8040 injection) in an effort to reach a total of ≥ 5 x 10\^6 CD34+ cells/kg and at least ≥ 2 x 10\^6 CD34+ cells/kg from the combined collections.
    id
    OG000
    title
    Arm 1: Donors
  2. description
    -All or part of the leukapheresis product will be infused into the recipient per institutional guidelines. The day of the infusion will be considered Day 0; if the infusion occurs over multiple days, the final day of infusion will be considered Day 0
    id
    OG001
    title
    Arm 2: Recipients
param Type
MEDIAN
population Description
Recipients are not evaluable for this outcome measure.
reporting Status
POSTED
time Frame
At 3-4 hours after BL-8040
title
Median Peripheral Blood CD34+ Cell Count (Arm 1 Donor Only)
type
SECONDARY
unit Of Measure
CD34/microliters

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice